First Quadrant’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-791
Closed -$63K 883
2016
Q4
$63K Hold
791
﹤0.01% 752
2016
Q3
$63K Sell
791
-9
-1% -$727 ﹤0.01% 763
2016
Q2
$62K Hold
800
﹤0.01% 693
2016
Q1
$44K Sell
800
-198,400
-100% -$10.8M ﹤0.01% 697
2015
Q4
$12.3M Sell
199,200
-14,600
-7% -$921K 0.27% 112
2015
Q3
$13.5M Buy
213,800
+10,700
+5% +$764K 0.3% 101
2015
Q2
$14.8M Buy
203,100
+166,900
+461% +$12.1M 0.31% 102
2015
Q1
$2.37M Buy
36,200
+35,600
+5,933% +$2.37M 0.05% 256
2014
Q4
$39K Hold
600
﹤0.01% 675
2014
Q3
$36K Buy
+600
New +$39.2K ﹤0.01% 708
2013
Q4
Sell
-53,600
Closed -$2.88M 840
2013
Q3
$2.88M Sell
53,600
-90,400
-63% -$4.66M 0.07% 259
2013
Q2
$6.57M Buy
+144,000
New +$6.24M 0.18% 162

Other funds holding STJ

First Quadrant's STJ Position: Q1 2017 in Review

First Quadrant sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 791 shares — an estimated $63K sold.

First Quadrant first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $14.8M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • First Quadrant reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • First Quadrant sold 791 St Jude Medical shares in Q1 2017, an estimated $63K.
  • First Quadrant first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
  • First Quadrant's St Jude Medical position peaked at $14.8M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on First Quadrant's 13F filing for Q1 2017, filed 25 Apr 2017.